Turning Point Brands Q3: Modern Oral sales surge 628%, net sales up 31% to $119M; FY guidance raised

Turning Point Brands, Inc.

2025-Q3 EPS reported $2.70 revenue$342,049,000

Consolidated net sales $119.0M (+31.2% YoY); Modern Oral sales $36.7M (+627.6%) now 30.8% of total.
Adjusted EBITDA $31.3M (+17.2%); net income $21.1M (+70.3%); diluted EPS $1.13, adjusted EPS $1.05.
2025 guidance raised: adjusted EBITDA to $115-120M (from $110-114M); Modern Oral sales to $125-130M.
Raised $97.5M net from ATM at $98.59/share; plans to amend ATM and buyback to $200M each.
Stoker's segment net sales up 80.8% to $74.8M; Zig-Zag down 10.5% to $44.2M; gross margins expand.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.